You are viewing the site in preview mode
Skip to main content
| |
KRAS-wt
n = 63
|
KRAS-mut
n = 38
|
P-value
|
|---|
|
Total cohort
|
26/63 (41.3%)
|
23/38 (60.5%)
|
0.068
|
|
Synchronous metastases
|
15/34 (44.1%)
|
14/22 (63.6%)
|
0.180
|
|
Metachronous metastases
|
11/29 (37.9%)
|
9/16 (56.3%)
|
0.348
|